Skip to main content

Table 2 The effect of TRPA1 antagonist 3 μg A-967079 on cystometry parameters of inflammatory rats

From: Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition

      

Compliance (μl/mmHg)

N-VC (number)

  

BP (mmHg)

PT (mmHg)

MP (mmHg)

ICI (min)

 

No-treatment

11.83 ± 2.96

12.74 ± 3.4

21.76 ± 1.63

4.80 ± 1.79

91.44 ± 18.19

0.25 ± 0.5

Control

Treatment

11.66 ± 3.32

12.42 ± 3.83

20.82 ± 2.84

4.76 ± 1.96

92.88 ± 43.76

0

 

Recovery

11.71 ± 3.19

12.73 ± 3.83

21.19 ± 2.22

4.68 ± 1.68

104.56 ± 40.19

0

 

No-treatment

10.54 ± 3.23

11.94 ± 2.88

22.68 ± 4.89

3.64 ± 0.78

80.07 ± 27.31

3.00 ± 0.82

Cystitis

Treatment

10.25 ± 3.99

12.00 ± 4.67

22.68 ± 5.28

5.87 ± 0.93*

67.40 ± 7.66

0.75 ± 0.50**

 

Recovery

9.85 ± 4.37

11.46 ± 4.75

21.96 ± 5.75

4.50 ± 1.59

90.86 ± 34.91

1.25 ± 0.50*

  1. Results were expressed as mean ± standard error. The “*” or “**” represented the difference was significant between the treatment or recovery and no-treatment in cystometry parameters. *P < 0.05, ** P < 0.01